Peptidyl-proline modification

pathway activity — cross-omics
GO:0018208Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-proline modification pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are P4HA2, PLOD2, and CRTAP, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-proline modification activity versus P4HA2 in BRCA (Pearson r = -0.06).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAP4HA2 →+0.598+0.037<.001<.00139
GBMPLOD2 →+0.923+0.050<.001.00238
BRCACRTAP →+0.580+0.039<.001<.00137
CCRCCGALNT2 →+0.586+0.045<.001<.00137
BRCAPLOD1 →+0.630+0.045<.001<.00137
BRCAVCL_S795 →+0.477+0.038<.001<.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018208 vs P4HA2 — BRCA

Per-sample scatter of Peptidyl-proline modification activity vs P4HA2 in BRCA.

Explore this scatter interactively →

Exploration